Brevan Howard Capital Management’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.49M | Buy |
26,994
+10,880
| +68% | +$601K | 0.01% | 785 |
|
|
2025
Q1 | $779K | Buy |
+16,114
| New | +$779K | 0.01% | 542 |
|
|
2024
Q3 | – | Sell |
-8,971
| Closed | -$311K | – | 1328 |
|
|
2024
Q2 | $311K | Buy |
+8,971
| New | +$311K | ﹤0.01% | 714 |
|
|
2024
Q1 | – | Sell |
-11,806
| Closed | -$271K | – | 1239 |
|
|
2023
Q4 | $271K | Buy |
+11,806
| New | +$271K | ﹤0.01% | 717 |
|